First Allied Advisory Services’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-35,000	Closed	-$223K	–	1205
2018 Q2	$223K	Buy	+35,000	New	+$223K	0.01%	1017